These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12631217)

  • 1. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.
    Halperin R; Zehavi S; Hadas E; Habler L; Bukovsky I; Schneider D
    Int J Gynecol Cancer; 2003; 13(1):32-7. PubMed ID: 12631217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
    Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
    Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected immunohistochemical prognostic factors in endometrial cancer.
    Markova I; Duskova M; Lubusky M; Kudela M; Zapletalová J; Procházka M; Pilka R
    Int J Gynecol Cancer; 2010 May; 20(4):576-82. PubMed ID: 20686376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of estrogen receptor, progesterone receptor, and Her-2/ neu in primary and extra-corporeal endometrial cancer.
    Tangjitgamol S; Tanvanich S; Srijaipracharoen S; Manusirivithaya S
    Histol Histopathol; 2013 Jun; 28(6):787-94. PubMed ID: 23255089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
    Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
    Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma.
    Vang R; Barner R; Wheeler DT; Strauss BL
    Int J Gynecol Pathol; 2004 Jul; 23(3):223-33. PubMed ID: 15213598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
    Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
    Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases.
    Ulbright TM; Roth LM
    Hum Pathol; 1985 Jan; 16(1):28-34. PubMed ID: 2982713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral effects of medroxy-progesterone on proliferation, apoptosis, and sex steroid receptors in endometrioid endometrial adenocarcinoma.
    Dahmoun M; Boman K; Cajander S; Bäckström T
    Gynecol Oncol; 2004 Jan; 92(1):116-26. PubMed ID: 14751147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
    Li M; Zhao L; Shen D; Li X; Wang J; Wei L
    Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases.
    Prat J; Matias-Guiu X; Barreto J
    Cancer; 1991 Dec; 68(11):2455-9. PubMed ID: 1933783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
    Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer.
    Kudela M; Pilka R; Lubusky M; Hejtmanek P; Dzubak P; Brychtova S
    Eur J Gynaecol Oncol; 2012; 33(2):159-63. PubMed ID: 22611955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
    Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E
    Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.